The findings of this study suggest that hepatic ischemia occurs after liver transplantation and that treating recipients with low-dose resveratrol before reperfusion may improve the graft survival by inhibiting UPR arms in particular (IRE1α and PERK). Here, ERN1 is linked to ischemia.